View article

There is currently a resurgence of interest in the study of suicidal ideation (SI), a main risk factor for suicidal behavior. 1 This resurgence may be explained by the net increase in the incidence of SI in the population during the COVID-19 pandemic, especially in young people. 2 Also, the research interest in new drugs capable of treating SI effectively and immediately indicates that this is a genuine therapeutic target, with the potential to reduce the incidence of suicidal acts. 3 Finally, with a view to prevention, several theories have focused in recent years on distinguishing between the processes involved in the generation of SI and those involved in the acts themselves, leading to question the “transition from ideas to acts.” 4 At the same time, recent US guidelines stated that whereas the screening of depression is recommended in primary care, such is not the case for SI. 5 This lack of recommendation has been …